Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Jan;13(1):58-67.
doi: 10.1007/BF00920636.

Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases

Affiliations

Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases

M al-Janadi et al. J Clin Immunol. 1993 Jan.

Abstract

We investigated serum levels of interleukin-6 (IL-6), interferon-gamma (IFN-gamma), and tumor necrosis factor alpha (TNF alpha) from patients with systemic lupus erythematosus (SLE) and its various clinical manifestations of disease and from patients with rheumatoid arthritis (RA) and other rheumatic diseases. The serum levels of IL-6 and IFN-gamma were highly elevated from patients with SLE associated with lymphadenopathy (LN) or nephrotic syndrome (NS). On the contrary, the serum levels of TNF alpha were elevated from most patients with SLE associated with thrombocytopenia (TP). However, serum levels of TNF alpha were in the normal range from patients with SLE associated with NS, LN, or central nervous system disease. Of interest, patients with SLE associated with humoral immunodeficiency disorder, hypogammaglobulinemia, had highly elevated levels of serum IL-6. The concanavalin A-stimulated mononuclear cells (MNC) of patients with SLE associated with TP secreted highly elevated levels of TNF alpha compared to other patient groups. We suggest that abnormal production of various cytokines in SLE is an intrinsic defect of MNC and the immune system that may be the key element for a variety of clinical manifestations of this disease.

PubMed Disclaimer

References

    1. Arthritis Rheum. 1988 Nov;31(11):1358-64 - PubMed
    1. Clin Exp Immunol. 1988 Jun;72(3):446-9 - PubMed
    1. Clin Immunol Immunopathol. 1992 Apr;63(1):10-2 - PubMed
    1. Am J Med. 1986 Dec;81(6):1081-4 - PubMed
    1. Annu Rev Immunol. 1989;7:625-55 - PubMed

MeSH terms

LinkOut - more resources